Old Web
English
Sign In
Acemap
>
authorDetail
>
Anna Lotti Suffredini
Anna Lotti Suffredini
Medicine
Ligneous conjunctivitis
Clinical trial
Octapharma
Interim analysis
3
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Plasminogen Eye Drops Are Effective in Preventing Recurrence of Pseudomembranes in Ligneous Conjunctivitis: Results from the Phase 2/3 KB046 Trial
2020
Blood
Roberto Caputo
Maria Teresa Sartori
Andrea Leonardi
Anna Lotti Suffredini
Mirella Calcinai
Roberto Crea
Prasad Mathew
Charles Nakar
Neelam Thukral
Amy D. Shapiro
Show All
Source
Cite
Save
Citations (0)
High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy
2017
Neurological Sciences
Eduardo Nobile-Orazio
Dario Cocito
Chiara Briani
R. Plasmati
Angelo Schenone
Francesca Gallia
Ivan Marjanovic
Anna Lotti Suffredini
Show All
Source
Cite
Save
Citations (2)
Safety & Efficacy of Human Plasma Derived Plasminogen Ophthalmic Drops for Treatment of Ligneous Conjunctivitis: Report of Phase 2/3 Clinical Trial
2015
Blood
Charles Nakar
Roberto Caputo
Francis W. Price
Maria Teresa Sartori
Andrea Leonardi
Anna Lotti Suffredini
Neelam Thukral
Jacopo Secci
Bennie H. Jeng
Amy D. Shapiro
Show All
Source
Cite
Save
Citations (4)
1